Skip to main content
. 2018 Nov 29;13(11):e0208044. doi: 10.1371/journal.pone.0208044

Table 1. Treatment strategy for optimization of in vitro DN model.

Treatment Group AGE (150μg/ml) Ang II (1μM) HG (30 mM) Mannitol(30 mM)
1 - - - -
2 - - - +
3 - - + -
4 - + + -
5 + - + -
6 + + + -